Vertex Pharmaceuticals Inc./OS/Put [300]/MS
- BID
0.066
- ASK
0.08
- 10,000 Units10,000 Units
- 07/23, 12:46:31 PM
Product class
Warrant - Classic
Last exchange day
18/12/2026
Performance (1M)
6.76%
Basis price
300.0000 [USD]
Cap
- []
Leverage
52.44
Delta
-0.09
Agio p.a. in %
38.42 %
Implicit volatility
63.85 %
Ø Tradable bid size main / secondary
0/0
Ø Tradable ask size main / secondary
0/0
Spread main / secondary
0.00/0.00
Tax presence main / secondary
-/-
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 0.067 G | 0 Units |
| PRICE DETERMINATION TIME | 07/23/2026 / 10:27:05 AM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 0.067 | 0.065 |
| PREV. DAY'S PRICE | 0.069 | (07/22) |
| CHANGE DAY BEFORE | -0.00 | -2.90 % |
| 52 WEEK HIGH / LOW | (-) | (-) |
Indicators
| TIME OF CALCULATION | 12:49:24 PM (07/23/2026) |
| AGIO P.A. IN % | 38.42 % |
| LEVERAGE | 52.44 |
| DELTA | -0.09 |
| IMPLICIT VOLATILITY | 63.85 % |
| OMEGA | 4.49 |
| THETA | -0.58 |
| VEGA | 0.00 |
Master Data
| WKN | MM21LH |
| ISIN | DE000MM21LH3 |
| SYMBOL | - |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Leverage Product |
| PRODUCT CLASS | Warrant - Classic |
| PRODUCT NAME | Put Vertex Pharmaceuticals emittiert von Morgan Stanley & Co. Int. plc |
| ISSUER | Morgan Stanley & Co. International plc |
| TRADING SEGMENT | EASY EUWAX |
| OPTION TYPE | put |
| UNDERLYING | VERTEX PHARMACEUTICAL COM USD0.01 |
| BASIS PRICE | 300.0000 [USD] |
| CAP | - [] |
| KNOCKIN LEVEL | - [-] |
| RANGE | - - - |
| MULTIPLIER | 0.01 |
| EXERCISE TYPE | American |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | EUR |
| SETTLEMENT CURRENCY | Euro |
| SMALLEST TRADABLE UNIT | 1.00 |
| MINIMUM QUOTATION EUR | 3,000.00 |
| MINIMUM QUOTATION UNITS | 10,000.00 |
| LAST VALUATION DAY | 18/12/2026 |
| PAYMENT DATE | 28/12/2026 |
| FIRST EXCHANGE DAY | 13/08/2025 |
| LAST EXCHANGE DAY | 18/12/2026 |
| TRADING HOURS | 08:00:00 AM - 10:00:00 PM |
| QUOTATION | fortlaufende Auktion |
| ISSUE VOLUME | 74,000,000 |
| QUANTO | No |
Underlying
| WKN | 882807 |
| ISIN | US92532F1003 |
| SYMBOL | VX1 |
| NOMINAL CURRENCY | Euro |
| TYPE OF UNDERLYING | Equity |
| COUNTRY OF THE HOME STOCK EXCHANGE | Germany |
Issuer
| NAME | Morgan Stanley & Co. International plc |
| ADDRESS | Morgan Stanley & Co. International plc
25 Cabot Square, Canary Wharf
E14 4QA London
Großbritannien |
| EMAIL ADDRESS | strukturierte-produkte@morganstanley.com |
| SERVICE PHONE NUMBER | 069 21661234 |
| URL | https://zertifikate.morganstanley.com/ |
| DOCUMENTS | PRIIP / KID (english) |
| ISSUER PORTRAIT | PDF |
Product Description
This (put) warrant is linked to Vertex Pharmaceuticals Inc., the underlying instrument, and has a term ending on December 28, 2026. This is a leveraged product, where the investor participates disproportionately in the positive and negative performance of the underlying. The investor has the right to exercise throughout the term of the warrant. Upon exercise, the redemption amount is calculated as the difference between the strike price and the price of the underlying, adjusted for the multiplier of 0.01. Exercise occurs automatically at the end of the term. If, at that point in time, the price of the underlying is above the strike price, the product will expire worthless.